Targeting the biology of aging

Aging is the biggest risk factor for most chronic diseases. Groundbreaking research has demonstrated that biological aging processes are modifiable and caused by a discrete number of mechanisms. Life Bio is developing a novel partial epigenetic reprogramming platform that targets a key underlying mechanism of aging to prevent and reverse age-related diseases with significant unmet need to extend healthy human lifespan. This approach holds the promise of treating many of the most debilitating and chronic diseases of our time.